ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Lees Pharmaceutical Holdings Ltd (PK)

Lees Pharmaceutical Holdings Ltd (PK) (LPCUF)

0.1903
0.00
(0.00%)
終了 7月4日 5:00AM

Lees Pharmaceutical Holdings Ltd (PK) (LPCUF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.1903
( - )
買値
0.0001
売値
289,600.20
出来高
-
0.00 日の範囲 0.00
0.1882 52 週間の範囲 0.1903
時価総額
前日終値
0.1903
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 775,233
発行済株式数
588,835,343
配当利回り
0.05 (4.13%)
PER
6.6
1 株当たり利益 (EPS)
0.16
歳入
1.44B
純利益
91.94M

Lees Pharmaceutical Holdings Ltd (PK) について

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare di... Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin’s disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong. 詳細を表示

セクター
Healthcare
業界
Pharmaceuticals
ウェブサイト
本社
Sha Tin, Hong Kong
設立
1994
Lees Pharmaceutical Holdings Ltd (PK) is listed in the Healthcare sector of the その他OTC with ticker LPCUF. The last closing price for Lees Pharmaceutical (PK) was US$0.19. Over the last year, Lees Pharmaceutical (PK) shares have traded in a share price range of US$ 0.1882 to US$ 0.1903.

Lees Pharmaceutical (PK) currently has 588,835,343 shares in issue. The market capitalisation of Lees Pharmaceutical (PK) is US$112.06 million. Lees Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of 6.60.

LPCUF 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
12000.19030.19030.190300CS
26000.19030.19030.190300CS
520.00211.115834218920.18820.19030.1882190.1903CS
156-0.0097-4.850.20.20.1882250.18928182CS
260-1.3541-87.67806267811.54441.54440.00015530.28971906CS

LPCUF - Frequently Asked Questions (FAQ)

What is the current Lees Pharmaceutical Holdings Ltd (PK) share price?
The current share price of Lees Pharmaceutical Holdings Ltd (PK) is US$ 0.1903
How many Lees Pharmaceutical Holdings Ltd (PK) shares are in issue?
Lees Pharmaceutical Holdings Ltd (PK) has 588,835,343 shares in issue
What is the market cap of Lees Pharmaceutical Holdings Ltd (PK)?
The market capitalisation of Lees Pharmaceutical Holdings Ltd (PK) is USD 112.06M
What is the 1 year trading range for Lees Pharmaceutical Holdings Ltd (PK) share price?
Lees Pharmaceutical Holdings Ltd (PK) has traded in the range of US$ 0.1882 to US$ 0.1903 during the past year
What is the PE ratio of Lees Pharmaceutical Holdings Ltd (PK)?
The price to earnings ratio of Lees Pharmaceutical Holdings Ltd (PK) is 6.6
What is the cash to sales ratio of Lees Pharmaceutical Holdings Ltd (PK)?
The cash to sales ratio of Lees Pharmaceutical Holdings Ltd (PK) is 0.42
What is the registered address of Lees Pharmaceutical Holdings Ltd (PK)?
The registered address for Lees Pharmaceutical Holdings Ltd (PK) is Building 20E, Sha Tin, New Territories
What is the Lees Pharmaceutical Holdings Ltd (PK) website address?
The website address for Lees Pharmaceutical Holdings Ltd (PK) is www.leespharm.com
Which industry sector does Lees Pharmaceutical Holdings Ltd (PK) operate in?
Lees Pharmaceutical Holdings Ltd (PK) operates in the Pharmaceuticals sector

LPCUF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock